| Literature DB >> 21293321 |
Abstract
Achieving operational tolerance after liver transplantation remains a challenge for clinicians and scientists. Prospective immunosuppression withdrawal trials coupled with biomarker development and histologic assessment will be critical to the increasing applicability of drug-free transplantation from a sporadic event to a safely achieved, predictable state for increasing numbers of patients.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21293321 DOI: 10.1097/TP.0b013e31820c85a3
Source DB: PubMed Journal: Transplantation ISSN: 0041-1337 Impact factor: 4.939